Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer
While more than four decades have elapsed since intravesical Bacillus Calmette-Guérin (BCG) was first used to manage non-muscle invasive bladder cancer (NMIBC), its precise mechanism of anti-tumor action remains incompletely understood. Besides the classic theory that BCG induces local (within the b...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
IMR Press
2024-08-01
|
| Seri Bilgileri: | Frontiers in Bioscience-Landmark |
| Konular: | |
| Online Erişim: | https://www.imrpress.com/journal/FBL/29/8/10.31083/j.fbl2908295 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|